Quantcast

Drug Delivery Technologies: Worldwide Market Analysis 2015-2018 and Forecast 2019-2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Drug Delivery Technologies Market Analysis & Trends – Industry Forecast
to 2027”
report has been added to ResearchAndMarkets.com’s
offering.

The Global Drug Delivery Technologies Market is poised to grow strong
during the forecast period 2017 to 2027.

Some of the prominent trends that the market is witnessing include
growing focus on pediatric and geriatric patients, rising demand for
advancement in technologies, increase in the transformation in lifestyle
owing to rising urbanization.

This industry report analyzes the market estimates and forecasts of all
the given segments on global as well as regional levels presented in the
research scope.

The study provides historical market data for 2015, 2016 revenue
estimations are presented for 2017 and forecasts from 2018 till 2027.
The study focuses on market trends, leading players, supply chain
trends, technological innovations, key developments, and future
strategies.

With comprehensive market assessment across the major geographies such
as North America, Europe, Asia Pacific, Middle East, Latin America and
Rest of the world the report is a valuable asset for the existing
players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from
industry professionals across the value chain. A special focus has been
made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain,
France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.

This report provides data tables, includes charts and graphs for visual
analysis.

Report Highlights:

  • The report provides a detailed analysis on current and future market
    trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base
    numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other
    trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments

Key Topics Covered

1 Market Outline

1.1 Research Methodology

1.2 Market Trends

1.3 Regulatory Factors

1.4 End User Analysis

1.5 Strategic Benchmarking

1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview

3.1 Current Trends

3.1.1 Growing Focus on Pediatric & Geriatric Patients

3.1.2 Rising Demand for Advancement in Technologies

3.1.3 Increase in the Transformation in Lifestyle Owing to Rising
Urbanization

3.1.4 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

4 Drug Delivery Technologies Market, By Route of Administration

4.1 Ocular Drug Delivery

4.1.1 Ocular Devices

4.1.1.1 Ocular Inserts

4.1.1.2 Drug-Coated Contact Lenses

4.1.2 Formulations

4.1.2.1 Semi-Solid Formulations

4.1.2.1.1 Eye Ointments

4.1.2.1.2 Gels

4.1.2.2 Liquid Formulations

4.1.2.2.1 Liquid Sprays

4.1.2.2.2 Eye Drops

4.2 Transmucosal Drug Delivery

4.2.1 Oral Transmucosal Drug Delivery

4.2.1.1 Sublingual Drug Delivery

4.2.1.2 Buccal Drug Delivery

4.2.2 Other Transmucosal Drug Delivery

4.2.2.1 Vaginal Transmucosal Drug Delivery

4.2.2.2 Rectal Transmucosal Drug Delivery

4.3 Pulmonary Drug Delivery

4.3.1 Devices

4.3.1.1 Dry Powder Inhalers

4.3.1.2 Metered Dose Inhalers

4.3.1.3 Nebulizers

4.3.1.3.1 Jet Nebulizers

4.3.1.3.2 Soft Mist Nebulizers

4.3.1.3.3 Ultrasonic Nebulizers

4.3.2 Formulations

4.4 Nasal Drug Delivery

4.4.1 Nasal Powders

4.4.2 Nasal Drops

4.4.3 Nasal Gels

4.4.4 Nasal Sprays

4.5 Parenteral Route

4.5.1 Intra-arterial

4.5.2 Intramuscular

4.5.3 Intravenous

4.5.4 Subcutaneous route

4.6 Oral Drug Delivery

4.6.1 Liquid Oral Drugs

4.6.1.1 Syrups

4.6.1.2 Solutions

4.6.2 Semi-Solid Oral Drugs

4.6.2.1 Emulsions

4.6.2.2 Elixirs

4.6.2.3 Gels

4.6.3 Solid Oral Drugs

4.6.3.1 Capsules

4.6.3.2 Pills

4.6.3.3 Tablets

4.6.3.4 Powders

4.7 Topical Drug Delivery

4.7.1 Transdermal Drug Delivery

4.7.1.1 Transdermal Gels

4.7.1.2 Transdermal Patches

4.7.2 Formulations

4.7.2.1 Semi-Solid Topical Drug Delivery

4.7.2.1.1 Pastes

4.7.2.1.2 Creams

4.7.2.1.3 Lotions

4.7.2.1.4 Ointments

4.7.2.2 Solid Topical Drug Delivery

4.7.2.2.1 Powders

4.7.2.2.2 Suppositories

4.7.2.3 Liquid Topical Drug Delivery

4.7.2.3.1 Suspensions

4.7.2.3.2 Solutions

4.8 Injectable Drug Delivery

4.8.1 Formulations

4.8.1.1 Novel Drug Delivery Formulations

4.8.1.2 Long-Acting Injection Formulations

4.8.1.3 Conventional Drug Delivery

4.8.2 Devices

4.8.2.1 Self-Injection Devices

4.8.2.1.1 Autoinjectors

4.8.2.1.2 Wearable Injectors

4.8.2.1.3 Needle-Free Injectors

4.8.2.1.4 Pen Injectors

4.8.2.2 Conventional Injection Devices

4.8.2.2.1 Material

4.8.2.2.1.1 Plastic

4.8.2.2.1.2 Glass

4.8.2.2.2 Product

4.8.2.2.2.1 Prefilled Syringes

4.8.2.2.2.2 Fillable Syringes

4.8.2.2.3 Usability

4.8.2.2.3.1 Disposable Syringes

4.8.2.2.3.2 Reusable Syringes

4.8.2.2.4 Other Injector Devices

4.9 Implantable Drug Delivery

4.9.1 Passive Implantable Drug Delivery

4.9.2 Active Implantable Drug Delivery

4.10 Inhalation Route

5 Drug Delivery Technologies Market, By End User

5.1 Ambulatory Surgical Centers

5.2 Clinics

5.3 Diagnostic Centers

5.4 Home Care Settings

5.5 Other End Users

6 Drug Delivery Technologies Market, By Geography

6.1 North America

6.2 Europe

6.3 Asia Pacific

6.4 Middle East

6.5 Latin America

6.6 Rest of the World (RoW)

7 Key Player Activities

7.1 Acquisitions & Mergers

7.2 Agreements, Partnerships, Collaborations and Joint Ventures

7.3 Product Launch & Expansions

7.4 Other Activities

8 Leading Companies

8.1 Sanofi

8.2 Merck & Co. Inc.

8.3 Roche Holding AG

8.4 Pfizer Inc.

8.5 3M

8.6 Vectura Group PLC

8.7 Antares Pharma Inc.

8.8 Bayer AG

8.9 Becton, Dickinson and Company

8.10 GlaxoSmithKline PLC

8.11 Alkermes

8.12 Johnson & Johnson

8.13 Aradigm Corp.

8.14 Generex Biotechnology

8.15 Novartis AG

For more information about this report visit https://www.researchandmarkets.com/r/nxxay2

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Drug
Delivery

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.